NTRB NTRB
Company Profile ↓Company Overview
NTRB (NTRB) is a publicly traded company listed on with a market capitalization of $35.06M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 42.3% CAGR over the past five years.
Recent Developments
- Jan 2026 Revenue of $2.04M (-4.8% YoY); net profit $-8.23M.
- Trailing 12 Months Year-on-year growth — revenue -4.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 42.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 42.30% |
| 1 Year: | -4.81% |
Stock Price Performance
| 1 Year: | -59.49% |
| 6 Months: | -36.84% |
| 3 Months: | -29.41% |
| 1 Month: | -4.95% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)40.40 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 42.3% over 5 years.
CONS
- Trading 66.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Apr 2016 | Jul 2016 | Oct 2016 | Apr 2017 | Jul 2017 | Oct 2017 | Apr 2018 | Jul 2018 | Oct 2018 | Apr 2019 | Jul 2019 | Oct 2019 | Apr 2020 | Jul 2020 | Oct 2020 | Apr 2021 | Jul 2021 | Oct 2021 | Apr 2022 | Jul 2022 | Oct 2022 | Apr 2023 | Jul 2023 | Oct 2023 | Apr 2024 | Jul 2024 | Oct 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 162.81K | 193.59K | 74.91K | 82.57K | 119.36K | 84.45K | 391.80K | 433.49K | 213.74K | 283.04K | 477.92K | 456.15K | 618.00K | 476.93K | 655.93K | 427.84K | 408.53K | 442.83K | 645.80K | - | 667.43K | 622.45K | 346.06K | 400.71K | 433.40K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 415.45K | 465.57K | 277.55K | 311.77K | 236.60K |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 237.88K | -716 | 75.34K | 200.49K | 151.80K | 268.19K | - | 299.67K | 159.72K | 164.79K | 101.56K | 191.03K | - | 251.98K | 156.88K | 68.50K | 88.94K | 196.80K |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.67M | 2.16M | 3.95M | 1.11M | 1.45M |
| Operating Income | -52.08K | -35.62K | -29.98K | -35.62K | -92.96K | -107.73K | -448.10K | -1.88M | -488.62K | -573.16K | -449.61K | -330.57K | -147.49K | -225.82K | -40.95K | -314.06K | -482.24K | -1.54M | -685.88K | -1.03M | -1.07M | -1.02M | -824.19K | -1.72M | -1.89M | -1.41M | -1.43M | - | -1.41M | -2.00M | -3.88M | -1.02M | -1.25M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.33M | -1.94M | -3.82M | -926.85K | -1.20M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.88K | 5.77K | 5.55K | 5.33K | 5.01K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.39M | -2.00M | -3.87M | -968.06K | -1.24M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -52.08K | -35.62K | -29.98K | -35.62K | -92.96K | -107.73K | -448.10K | -1.88M | -488.62K | -573.35K | -450.56K | -753.27K | -412.19K | -225.87K | -42.57K | -315.96K | -519.92K | -1.57M | -689.99K | -1.04M | -1.08M | -1.02M | -829.17K | -1.76M | -1.90M | -1.71M | -1.36M | - | -1.39M | -2.00M | -3.87M | -968.06K | -1.24M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 | -0.23 | -0.08 | -0.12 | -0.14 | -0.13 | -0.11 | -0.22 | -0.21 | -0.15 | -0.12 | - | -0.12 | -2.12 | -0.32 | - | -0.10 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 161.00K | 117.81K | 277.87K | 290.72K | 400.43K | 445.12K | 551.50K | 974.53K | 773.98K | 880.77K | - | 683.43K | 562.55K | 457.11K | - | 247.26K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 245.28K | 370.65K | 943.70K | - | 2.08M | 2.09M | 2.14M | 2.04M |
| Cost of Revenue | - | - | - | - | - | - | 1.33M | 1.22M | 1.40M | 1.47M |
| Gross Profit | - | - | - | - | 316.23K | - | 750.41K | 862.11K | 743.32K | 566.31K |
| Operating Expenses | - | - | - | - | - | - | 4.90M | 5.73M | 7.43M | 8.88M |
| Operating Income | -151.26K | -2.67M | -3.33M | -1.97M | -2.60M | - | -4.15M | -4.87M | -6.69M | -8.32M |
| EBITDA | - | - | - | - | - | - | -4.15M | -5.12M | -10.18M | -8.01M |
| Interest Expense | - | - | - | - | - | - | 8.29K | 75.81K | 21.41K | 22.54K |
| Pretax Income | - | - | - | - | - | - | -4.48M | -5.49M | -10.48M | -8.23M |
| Tax Provision | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Net Income | -151.26K | -2.67M | -3.33M | -2.72M | -2.93M | - | -4.48M | -5.49M | -10.48M | -8.23M |
| Diluted EPS | - | - | - | - | - | - | -0.53 | -0.69 | -0.99 | -2.58 |
| R&D Expense | - | - | - | - | - | 411.38K | 982.23K | 1.96M | 3.12M | 1.89M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jan 2016 | Oct 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 330 | - | 37.73K | 164.90K | 2.81M | 2.20M | 9.93M | - | 9.46M | 7.52M | 7.47M | 7.55M |
| Current Assets | - | - | - | - | - | - | - | - | 2.69M | 1.02M | 4.79M | 4.99M |
| Cash & Equivalents | 100 | 6.23K | 27.12K | - | 474.65K | 10.18K | 151.99K | - | 1.99M | 492.94K | 4.31M | 4.57M |
| Inventory | - | - | - | - | - | - | - | - | 229.34K | 168.60K | 212.04K | 117.99K |
| Receivables | - | - | - | - | - | - | - | - | 113.05K | 148.65K | 73.85K | 118.40K |
| Total Liabilities | 11.80K | - | 14.62K | - | - | 2.02M | 2.82M | - | 883.39K | 1.08M | 1.04M | 868.45K |
| Current Liabilities | 11.11K | - | 14.62K | 43.39K | 403.01K | 2.02M | 2.57M | - | 748.61K | 999.09K | 982.85K | 784.28K |
| Long Term Debt | 686 | - | 1.58K | 1.82K | - | - | - | - | 100.50K | 79.83K | 58.20K | 35.86K |
| Total Debt | - | - | - | - | - | - | - | - | 185.81K | 241.28K | 186.35K | 245.49K |
| Total Equity | -11.47K | - | 23.11K | 121.51K | 2.40M | 175.43K | 7.11M | - | 8.57M | 6.44M | 6.43M | 6.68M |
| Shares Outstanding | - | - | - | - | - | - | - | - | 7.84M | 8.87M | 11.11M | 12.17M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -147.92K | -92.86K | -1.11M | -894.47K | -297.06K | - | -2.99M | -3.53M | -4.63M | -5.13M |
| Investing Cash Flow | - | - | -404.16K | - | 66.99K | - | -79.30K | -51.76K | -92.04K | -5.32K |
| Financing Cash Flow | 174.90K | 65.76K | 1.98M | 430.25K | 371.87K | - | 160.07K | 2.09M | 8.54M | 5.40M |
| Capital Expenditure | - | - | -4.16K | - | - | - | -79.30K | -51.76K | -92.04K | -5.32K |
| Free Cash Flow | - | - | -1.11M | - | - | - | -3.07M | -3.58M | -4.72M | -5.14M |
| Net Change in Cash | - | - | - | - | - | - | -2.91M | -1.49M | 3.82M | 263.14K |
Ratios (Annual)
Figures in %.
| Metric | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | 33.5% | - | 36.1% | 41.3% | 34.7% | 27.8% |
| Operating Margin % | - | - | -1,358.1% | -531.4% | -275.1% | - | -199.5% | -233.6% | -312.7% | -408.4% |
| Net Margin % | - | - | -1,358.1% | -734.3% | -310.8% | - | -215.6% | -263.0% | -489.9% | -404.1% |
| ROE % | -654.6% | -2,199.0% | -138.5% | -1,551.4% | -41.2% | - | -52.3% | -85.2% | -163.1% | -123.2% |
| ROCE % | -654.6% | -2,199.0% | -138.5% | -1,122.6% | -35.3% | - | -47.6% | -74.7% | -103.1% | -123.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NTRB
The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPd0FZQ29mcGJlbHBrdzNWSnZlTU5hNkRyTmZLYy1sRmFTQmlxQ2FGS3FMYzJ1NGZESWl4MTRiSFUyWk1sb2pxTTlIdzhOcmtmRXpyZF82ZGMwUFVtbmpPeGZaY1h4OHRxcDZnUkhDTXI1VThBMk5fMHV5RTkycXFLN2NSNUw?oc=5" targ…
Nutriband Inc. Revenue Breakdown – NASDAQ:NTRB - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBaMHZCcTVWQkxtMHVuVm1PME9qMzdfLWR5M19zbmZlUkpoQVhlajdDVklzdndIMVJiOVBZVXVOeVhFUldHd190N2pob1lOV01jYTZETUZmcmNxcTB6YzZSMi1VeXJaRHZpcG4yTlkwZ3dUdjBJZ093?oc=5" target="_blank">Nutriba…
NTRB|Nutriband Inc|Price:2.850|Chg%:-0.070 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBid2xWTUxDTldscUp4N09zSHZTa3BPY3c1WWhTVndYTFkzUHBMeGZyaFdPQWlVX1AtdXNZRWVZVU5BT3pOQl9hX3pUQ2NVN3pjSmhPeGZ0UGJlbThyalFWMjZWRmF1MlVRWkxfWS1B?oc=5" target="_blank">NTRB|Nutriband Inc|…
Nutriband Secures New Three-Year $5M Credit Facility - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQU05KZzVNblY1TzFhbFpFZTdTcFNqMFNtSWJVUjl2LXRkUC0wNmFMSC1TNUh0YUttQ3JaaWpkNFF0aDdhZmZWREFkMDZDdzN2Y1pFUWpZbm1hOVNOc2xuY1RqaGkwUW9nN3NNc3JvSDN4REo1WTVuRVpQbFZSTWltWjQxODdWdk1KT042aG…
Nutriband Inc. (NTRB) Holds Steady Near Support – Modest Uptick in Low-Volume Trade - Collar Trade - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOU0pMZVZTdjdRbUJiaW03UWt5WDR2cVI0ZUJRTU44VlgzWk8ycUdNSGowSVBVRVh5WW1hQ3RmTzVybEpwUG1JN0xYc3dHYnFYY2tTRThKdzBPV0U2S0VvN24tS1Z0OEpxVHdQMWtwTEdTOW1nRVRsTFBGOU52WlJMaHlkZ0NEYUtLSzlVbD…
(NTRB) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNOFY2WmVkTjJOVzZ5N2NUMzhKaUhJeVZiUFFKejd3Qzg4YU5BMFlhQi13MEdwZTFqM2t5R3g2bS15NW9DSHh3eUZISkVDa2tjYXZJa2NKQVFKNFhzeTlYdU5SNWxNUkpfTXJXTnd4d19kWTlrYzlWdjZxanNEWTlEQzE3MjR3RldIMjdLcG…
NTRB — Frequently Asked Questions
What is the current share price of NTRB?
As of 2026-08-05 17:25 PDT, NTRB trades at $2.88 on NASDAQ/NYSE. Its 52-week range is $2.81 to $8.50.
What is the market capitalisation of NTRB?
NTRB has a market capitalisation of $35.06M on NASDAQ/NYSE.
What is the P/E ratio of NTRB?
NTRB trades at a trailing price-to-earnings (P/E) ratio of -1.12. Its price-to-book (P/B) ratio is 5.25.
What is the return on equity (ROE) of NTRB?
NTRB has a return on equity (ROE) of -123.21%. Its return on capital employed (ROCE) is -122.98%.
Is NTRB a good stock to buy?
This page provides a data-driven analysis of NTRB, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.